Skip to content Skip to footer
Subscribe Now
VIEWPOINTS_Andrew Menzies-Gow2_2024
VIEWPOINTS

Andrew Menzies-Gow Shares Insights from Phase III MANDARA Trial of Fasenra for EGPA Patients

Shots  While sharing the details on Fasenra, Andrew highlights the unmet medical need in the healthcare sector as there’s only one approved treatment for EGPA  With mepolizumab as the comparator drug for the trial, Andrew shares the positive results in achieving remission rates. Andrew sheds light on the unique mechanism of benralizumab that directly targets…
December 4, 2023

Read more

VIEWPOINTS_Betty Woo_2023
VIEWPOINTS

In an Insightful Conversation with PharmaShots, Betty Woo Highlights Thermo Fisher’s Cell Therapy Collaboration Program

Shots:   Betty Woo, VP of Cell, Gene, and Advanced Therapies, Thermo Fisher Scientific discusses the evolution of ThermoFisher’s strategic collaboration with ArsenalBio    Betty highlights the development of programmable autologous T cells for the treatment of cancer and the cell therapy collaboration program   Betty believes that through innovation and partnership, they can tap into the full…
November 30, 2023

Read more

VIEWPOINTS_Moitreyee Chatterjee-Kishore_2023
VIEWPOINTS

Moitreyee Chatterjee-Kishore, in an absorbing conversation with PharmaShots, shares the highlights of the SPOTLIGHT & GLOW study

Shots:   Moitreyee Chatterjee-Kishore, HOD, Immuno-Oncology & Cancer Cell Therapy at Astellas shares insights from the P-III trials (SPOTLIGHT & GLOW)   In SPOTLIGHT and GLOW, zolbetuximab and chemotherapy demonstrated improved PFS and OS vs placebo plus chemotherapy, yielding positive outcomes for patients with advanced gastric or GEJ cancer.   Moitreyee highlights the ongoing clinical trials for the…
November 29, 2023

Read more

VIEWPOINTS_Michael Irizarry_2023
VIEWPOINTS

Michael Irizarry shares insights from the P-III clinical study of LEQEMBI, for the treatment of Alzheimer’s disease

Shots: Michael Irizarry, Senior VP of Clinical Research and Deputy Chief Clinical Officer, Alzheimer’s Disease and Brain Health at Eisai in a stimulating conversation with PharmaShots Michael shares insights from the P-III clinical study Clarity AD of LEQEMBI for the treatment of Alzheimer’s disease The study highlights that LEQEMBI treatment met the primary endpoint and…
November 27, 2023

Read more

Asia Healthcare Week 2024 The Home of Asia's Largest Healthcare Gathering
EVENTS

Asia Healthcare Week 2024: The Home of Asia’s Largest Healthcare Gathering

Asia Healthcare Week (AHW) is the region’s #1 mega show bringing together all healthcare leaders in the primary, community and consumer health sectors. Registration Link: https://www.ahwdigital.com.au/events-asiahealthcareweek/srspricing Discount Code: “PharmaShot10” for 10% discount off tickets, applicable on top of early-bird promotions This is the only gathering in Asia that will unite the front-line healthcare service providers, clinical operations…
November 21, 2023

Read more

VIEWPOINTS_Matthew G. Fishler_2023
VIEWPOINTS

Matthew G. Fishler Shares the Highlights of AVEIR DR, the World’s First Dual-Chamber Leadless Pacemaker System

Shots:  Matthew G. Fishler, Chief Engineer and Director of Product Development Abbott’s Cardiac Rythm Management Business, in an insightful conversation with PharmaShots   Matthew shares the highlights of the recently approved AVEIR Dr, the world’s first dual-chamber leadless pacemaker system for patients with slower-than-normal or abnormal heart rhythms   Equipped with i2i™ communication technology, AVIER DR eliminates…
November 20, 2023

Read more

VIEWPOINTS_Jane Reed_2023
VIEWPOINTS

Jane Reed Highlights the Growing Dependence of NLP to Comply with the Regulatory Guidelines

Shots:  In an invigorating conversation with PharmaShots, Jane Reed discusses the transition from document-driven to data-driven decision-making in the pharmaceutical industry   Jane sheds light on the increasing dependence on AI and ML in regulatory affairs and how it helps pharma companies mitigate errors, discrepancies, and non-compliance   Jane highlights the benefits of NLP in ensuring regulatory…
November 16, 2023

Read more

VIEWPOINTS_Jennifer Davidson_2023
VIEWPOINTS

Jennifer Davidson Highlights the Data from the Phase 3 QUASAR Induction Study 1

Shots:  Jennifer Davidson, VP, of Medical Affairs Immunology, Johnson & Johnson Innovative Medicine shares insights from the data of the Phase III QUASAR induction study presented at the DDW'23  P-III QUASAR induction study 1 demonstrated positive results in patients who received TREMFYA 200 mg vs Placebo, with most of the patients achieving remission at week…
November 13, 2023

Read more

VIEWPOINTS_Micah Litow_2023
VIEWPOINTS

Micah Litow shares insights from the 2023 Kalderos Annual Report on drug discount programs

Shots:  Micah Litow, in a stimulating conversation with PharmaShots, shares insights from the 2023 Kalderos Annual Report on drug discount programs   Micah highlights the challenges the drug manufacturers, covered entities, and state payers face on account of US drug discount programs   Micah sheds light on how Kalderos' MDRP Discount Monitoring solution helps drug manufacturers prevent…
November 9, 2023

Read more

Thoughtspot_Saurabh_Chaubey
THOUGHTSPOT

Robotic Process Automation in Pharmaceutical Industry (RPA in Pharma)

Shots:  Efficient, time-savvy, and promising, automation helps companies navigate the unexplored areas of businesses and unlocks the door to new opportunities. PharmaShots brings this month an informative take on RPA in the Pharmaceutical Industry with this article  RPA bots aim to automate repetitive tasks and reduce human involvement in less productive work to boost efficiency.…
November 8, 2023

Read more

Load more